NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/05/2026
Back to search
Official data from USPTO
CYTOARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
05/05/2026
Trademark type
Word
Nice classes
44
Filing date
05/09/2024
Registration date
05/05/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2026
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2020-06-00
First use in commerce
2020-06-00
Drawing code
4
Owner type
99
Owner location
Taipei, TW
Examiner
SETTLES LEWIS, SHAILA E
Law office
P10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CytoArm Co., Ltd.
Representatives
Michael T. Smith Birch Stewart Kolasch & Birch LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical services in the field of genetic disorderscancersrare diseasescardiovascular and immunological diseases and disorders; Health care servicestreatment of patients with genetic disorderscancersrare diseasescardiovascular and immunological diseases and disorders; Medical servicespathological medical examination and biochemical examination for medical purposes; Preparation of prescriptions by pharmacists; Providing pharmacy informationconsultancy and advisory services regarding preparation of prescriptions in pharmacies; Providing medical informationconsultancy and advisory services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Regenerative medicine services; Medical treatment using cultured cells; Cultured cell bank services for medical transplantation; Genetic testing for diagnostic or treatment purposes; Medical examination; Human tissue bank services
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/10/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/10/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/18/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/18/2026
IUAF
USE AMENDMENT FILED
09/10/2025
EISU
TEAS STATEMENT OF USE RECEIVED
09/10/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/08/2025
PUBO
PUBLISHED FOR OPPOSITION
04/08/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/08/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/08/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/08/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/22/2024
GNRT
NON-FINAL ACTION E-MAILED
11/22/2024
CNRT
NON-FINAL ACTION WRITTEN
11/22/2024
DOCK
ASSIGNED TO EXAMINER
11/22/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2024
NWAP
NEW APPLICATION ENTERED
05/09/2024
Continuous trademark protection
Get notified about every new filing that threatens CYTOARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.